IceCure Medical (ICCM) Raw Materials (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Raw Materials data on file, last reported at $1.8 million in Q4 2025.

• On a quarterly basis, Raw Materials rose 28.2% year-over-year to $1.8 million in Q4 2025; TTM through Dec 2025 was $1.8 million, a 28.2% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 28.2% from the prior year.
• Raw Materials for Q4 2025 stood at $1.8 million, up from $1.4 million in the prior quarter.
• Over the last five years, Raw Materials for ICCM reached as high as $1.8 million in Q4 2025 and fell as low as $704000.0 in Q4 2021.
• Historically, Raw Materials has averaged $1.4 million across 5 years, with a median of $1.4 million in 2024.
• Across the five-year window, Raw Materials surged 122.44% in 2022 and retreated 11.17% in 2023, its largest moves.
• Year by year, Raw Materials stood at $704000.0 in 2021, then soared by 122.44% to $1.6 million in 2022, then slipped by 11.17% to $1.4 million in 2023, then climbed by 1.22% to $1.4 million in 2024, then increased by 28.2% to $1.8 million in 2025.
• Per Business Quant data, the three most recent Raw Materials figures were $1.8 million in Q4 2025, $1.4 million in Q4 2024, and $1.4 million in Q4 2023.